Literature DB >> 8904993

The clinical safety of H1-receptor antagonists. An EAACI position paper.

G Passalacqua1, J Bousquet, C Bachert, M K Church, C Bindsley-Jensen, L Nagy, P Szemere, R J Davies, S R Durham, F Horak, K Kontou-Fili, H J Malling, P van Cauwenberge, G W Canonica.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8904993     DOI： 10.1111/j.1398-9995.1996.tb02109.x

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  12 in total

Review 1.  New insights into the second generation antihistamines.

Authors:  G M Walsh; L Annunziato; N Frossard; K Knol; S Levander; J M Nicolas; M Taglialatela; M D Tharp; J P Tillement; H Timmerman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Cardiac effects of ebastine and other antihistamines in humans.

Authors:  A J Moss; J Morganroth
Journal:  Drug Saf       Date:  1999       Impact factor: 5.606

3.  Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance.

Authors:  Eef L Theunissen; Annemiek Vermeeren; Johannes G Ramaekers
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

4.  Second-generation antihistamines: a comparative review.

Authors:  J W Slater; A D Zechnich; D G Haxby
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

5.  Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine.

Authors:  S Matsumoto; Y Yamazoe
Journal:  Br J Clin Pharmacol       Date:  2001-02       Impact factor: 4.335

Review 6.  Selecting the optimal oral antihistamine for patients with allergic rhinitis.

Authors:  Jeffrey M Lehman; Michael S Blaiss
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 7.  Comparative tolerability of second generation antihistamines.

Authors:  F Horak; U P Stübner
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.606

8.  Efficacy and tolerability comparison of ebastine 10 and 20mg with loratadine 10mg: a double-blind, randomised study in patients with perennial allergic rhinitis.

Authors:  R J Davies
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

9.  Maintenance of remission with low-dose olopatadine hydrochloride for itch in well-controlled chronic urticaria.

Authors:  Teruhiko Makino; Yoshiaki Takegami; Mati Ur Rehman; Yoko Yoshihisa; Waka Ishida; Takashi Toyomoto; Tadamichi Shimizu
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-09-19

10.  Actual therapeutic management of allergic and hyperreactive nasal disorders.

Authors:  Claudia Rudack
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2004-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.